Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
